This role is centred on providing scientific leadership and oversight of all the technical aspects within the local Fordham immunoassay group, and throughout the wider Resolian immunoassay teams.

You will be responsible for providing supervision, guidance, and expertise, in order to facilitate the delivery of high quality methods and sample analysis results to our customers in compliance with GLP/GCP.

About RxCelerate
The RxCelerate group provides a platform for out-sourced drug discovery and development services and has a client base ranging from virtual biotech companies to multinational pharmaceutical companies. We design and deliver complete drug development programmes and project management for our clients from inception through to Phase II clinical studies.

This role will support the growth and visibility of RxCelerate and its affiliates by contributing to both business development activities and marketing and communications initiatives.

Associate Principal Scientist – Large Molecule Bioanalysis

UK – Hoddesdon

Pharmaron is a leading global Contract Research Organisation (CRO), supporting pharmaceutical and biotechnology companies across the full drug discovery and development lifecycle. With more than 25,000 employees across 23 sites in the UK, US, and China, we deliver fully integrated scientific services that help accelerate the development of novel therapies.

Company Description

This role is centred on providing scientific leadership and oversight of all the technical aspects within the local Fordham immunoassay group, and throughout the wider Resolian immunoassay teams.

You will be responsible for providing supervision, guidance, and expertise, in order to facilitate the delivery of high quality methods and sample analysis results to our customers in compliance with GLP/GCP.

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

About the role:

LifeArc is a self-funded not-for-profit medical research organisation.  

We have our own sources of income and therefore do not rely on fundraising or external grants to support our work. One key source is our main investment portfolio.

This new role will support our growing Investment team in the implementation of the investment strategy and mandate to ensure LifeArc outperforms its investment objective while in keeping with its sustainability goals and charitable objectives.